Phase 3 CBD Trial, Jiu-Jitsu Athletes, Pain, Sleep
Summary
A Phase 3 clinical trial (NCT07552974) registered by the NIH on ClinicalTrials.gov is investigating the effects of CBD on pain and sleep outcomes in Jiu-Jitsu athletes. The trial was started on September 1, 2022, and is classified as an interventional study examining a botanical CBD intervention for athletic performance and recovery. This registration provides public transparency on the trial's scope and participant population of 52 participants.
About this source
GovPing monitors ClinicalTrials.gov - Phase 3 Trials by Start Date for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 21 changes logged to date.
What changed
A new Phase 3 clinical trial (NCT07552974) has been registered on ClinicalTrials.gov by the NIH, investigating CBD (cannabidiol) as an intervention for pain and sleep outcomes specifically in Jiu-Jitsu athletes. The trial enrolled 52 participants and began on September 1, 2022.
Pharmaceutical companies and clinical investigators conducting cannabis-derived product research in athletic populations should note this trial as a reference for CBD study design and outcome measurement. Healthcare providers working with combat sport athletes may find relevance in emerging CBD efficacy data for pain and sleep management.
Archived snapshot
Apr 28, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Show glossary
Related changes
Get daily alerts for ClinicalTrials.gov - Phase 3 Trials by Start Date
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from NIH.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when ClinicalTrials.gov - Phase 3 Trials by Start Date publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.